We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Product News   Jul 11, 2017

 
Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Credit: Owlstone Medical

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Agilent Showcases Commitment to Sustainability at Analytica

Product News

Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260 and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency and transparency (ACT) certification.

READ MORE

Demystify Chromogenic Factor VIII Testing

Product News

For laboratories wishing to accurately quantify Factor VIII activity, there is now a ready-to-use Chromogenic Factor VIII Assay. The CRYOcheck™ assay is designed for ease of use and to minimize reagent waste. The assay is intended to identify Factor VIII deficiency and aid in the management of hemophilia A.

READ MORE

Cyted Acquires Pathognomics Ltd To Support Diagnostic Reporting Services

Product News

Cyted Ltd (“Cyted” or “the Company”), a developer and provider of artificial intelligence technology and digital diagnostic infrastructure, today announced it has acquired Pathognomics Limited, a provider of digital pathology and clinical diagnostic laboratory services, based in Huntingdon, Cambridgeshire, UK.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE